Par Pharmaceutical, Inc. Grabs New Jersey's JHP Pharmaceuticals For $490 Million
Published: Jan 22, 2014
Warburg Pincus LLC is selling JHP Group Holdings LLC to TPG Capital LP-backed Par Pharmaceutical Cos. Inc. for $490 million only one year after acquiring the company, sources said. The deal was announced without terms on Tuesday, Jan. 21. Parsippany, N.J.-based JHP Group is the parent company of JHP Pharmaceuticals, a pharmaceutical company that acquires, develops, manufactures and sells sterile injectable drugs.
Help employers find you! Check out all the jobs and post your resume.